Drug Information
| Drug General Information | |||||
|---|---|---|---|---|---|
| Drug ID |
D0K8DH
|
||||
| Former ID |
DNC012641
|
||||
| Drug Name |
4-Biphenyl-4-yl-2-hexyl-1H-imidazole
|
||||
| Drug Type |
Small molecular drug
|
||||
| Indication | Discovery agent | Investigative | [1] | ||
| Structure |
|
Download2D MOL |
|||
| Formula |
C21H24N2
|
||||
| Canonical SMILES |
CCCCCCC1=NC=C(N1)C2=CC=C(C=C2)C3=CC=CC=C3
|
||||
| InChI |
1S/C21H24N2/c1-2-3-4-8-11-21-22-16-20(23-21)19-14-12-18(13-15-19)17-9-6-5-7-10-17/h5-7,9-10,12-16H,2-4,8,11H2,1H3,(H,22,23)
|
||||
| InChIKey |
LLLKBKRUIUYVOU-UHFFFAOYSA-N
|
||||
| PubChem Compound ID | |||||
| Target and Pathway | |||||
| Target(s) | Sodium channel | Target Info | Inhibitor | [1] | |
| Voltage-gated sodium channel subunit alpha Nav1.3 | Target Info | Inhibitor | [1] | ||
| KEGG Pathway | Dopaminergic synapse | ||||
| Reactome | Interaction between L1 and AnkyrinsR-HSA-445095:Interaction between L1 and Ankyrins | ||||
| References | |||||
| REF 1 | Bioorg Med Chem Lett. 2004 Jul 5;14(13):3521-3.2-Alkyl-4-arylimidazoles: structurally novel sodium channel modulators. | ||||
If You Find Any Error in Data or Bug in Web Service, Please Kindly Report It to Dr. Zhou and Dr. Zhang.